1. Volume 199, Issue 1, Pages 147-154 (January 2018)
Efficacy and Safety of Enzalutamide vs Bicalutamide in Younger and Older Patients with Metastatic Castration Resistant Prostate Cancer in the TERRAIN Trial 
D. Robert Siemens, Laurence Klotz, Axel Heidenreich, Simon Chowdhury, Arnauld Villers, Benoit Baron, Steve van Os, Nahla Hasabou, Fong Wang, Ping Lin, Neal D. Shore 
The Journal of Urology 
Volume 199, Issue 1, Pages (January 2018)
DOI: /j.juro
Copyright © 2018 American Urological Association Education and Research, Inc. Terms and Conditions

2. Figure 1
Kaplan-Meier curve of progression-free survival on enzalutamide (ENZA) and bicalutamide (BIC) by age group. Radiographic disease progression component was assessed by independent central review.
The Journal of Urology  , DOI: ( /j.juro )
Copyright © 2018 American Urological Association Education and Research, Inc. Terms and Conditions

3. Figure 2
Kaplan-Meier plot of time to prostate specific antigen progression for enzalutamide (ENZA) and bicalutamide (BIC) by age group.
The Journal of Urology  , DOI: ( /j.juro )
Copyright © 2018 American Urological Association Education and Research, Inc. Terms and Conditions